Proactive Wealth Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.39M Buy
9,106
+4,810
+112% +$4.88M 1.58% 15
2025
Q4
$4.62M Buy
4,296
+351
+9% +$336K 1.83% 12
2025
Q3
$3.01M Buy
3,945
+2,547
+182% +$1.9M 1.3% 25
2025
Q2
$1.09M Buy
1,398
+74
+6% +$57.5K 0.51% 62
2025
Q1
$1.09M Buy
1,324
+68
+5% +$56.6K 0.58% 56
2024
Q4
$969K Buy
1,256
+814
+184% +$674K 0.5% 54
2024
Q3
$392K Buy
+442
New +$397K 0.22% 87

Other funds holding LLY

Proactive Wealth Strategies's LLY Position: Q1 2026 in Review

Proactive Wealth Strategies increased its Eli Lilly (LLY) stake by 112% in Q1 2026, buying an estimated $4.88M and bringing the position to 9,106 shares worth $8.39M. The position accounts for 1.58% of the portfolio, ranked #15.

Proactive Wealth Strategies first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Proactive Wealth Strategies held 9,106 shares of Eli Lilly worth $8.39M as of Q1 2026.
  • Proactive Wealth Strategies bought 4,810 Eli Lilly shares in Q1 2026, an estimated $4.88M.
  • Eli Lilly made up 1.58% of Proactive Wealth Strategies's portfolio in Q1 2026, its #15 holding.
  • Proactive Wealth Strategies first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • 4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Proactive Wealth Strategies's 13F filing for Q1 2026, filed 29 Apr 2026.